Use of the Connor-Davidson Resilience Scale in a complex medical dermatology clinic: Cross-sectional study evaluating associations between resilience, health-related quality of life, and mental health - 24/03/25
Doi : 10.1016/j.jaad.2025.02.082
Caroline J. Stone, BA a, Eliza Broadbent, MPH a, Vikram N. Sahni, MD b, Laurel Gray, MD b, Jennie T. Clarke, MD b, Christopher B. Hansen, MD b, Jamie L.W. Rhoads, MD, MS b, John J. Zone, MD b, Christopher M. Hull, MD b, Yelena P. Wu, PhD b, c, Jacob Kean, PhD d, e, Aaron M. Secrest, MD, PhD b, d, f, Zachary H. Hopkins, MD b, ⁎ 
a University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, Utah
b Department of Dermatology, University of Utah Spencer F Eccles School of Medicine, Salt Lake City, Utah
c Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
d Department of Population Health Sciences, University of Utah, Salt Lake City, Utah
e Division of Health System Innovation and Research, University of Utah, Salt Lake City, Utah
f Department of Dermatology, Te Whatu Ora–Waitaha Canterbury (Health New Zealand), Christchurch, New Zealand
∗Correspondence to: Zachary Hopkins, MD, University of Utah, Department of Dermatology, 30 N 1900 E, 4A330, Salt Lake City Utah, 84132University of UtahDepartment of Dermatology30 N 1900 E4A330Salt Lake CityUtah84132
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Monday 24 March 2025
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Key words : autoimmune disease, bullous diseases, connective tissue disease, outcomes, quality of life, rheumatic diseases
| Funding sources: This study was funded by a grant from the American Skin Association. Dr Secrest was funded by a Public Health Career Development Award from the Dermatology Foundation. These associations/foundations played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. |
|
| Patient consent: All patients were consented prior to completing the Connor-Davidson Resiliency Scale and participating in the study (see IRB). The clinical data connected to the patient and their CD-RISC score was collected retrospectively. |
|
| IRB approval status: This study was approved by the University of Utah Institutional Review Board (#00144454). |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?